Burns
Volume 32, Issue 3 , Pages 319-327 , May 2006

An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor

  • Ceren Alemdaroğlu

      Affiliations

    • Department of Pharmaceutical Technology, Gazi University, Faculty of Pharmacy, 06330 Etiler, Ankara, Turkey
    • ,
  • Zelihagül Değim

      Affiliations

    • Department of Pharmaceutical Technology, Gazi University, Faculty of Pharmacy, 06330 Etiler, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 212 21 07; fax: +90 312 212 79 58.
    • ,
  • Nevin Çelebi

      Affiliations

    • Department of Pharmaceutical Technology, Gazi University, Faculty of Pharmacy, 06330 Etiler, Ankara, Turkey
    • ,
  • Fatih Zor

      Affiliations

    • Department of Plastic and Reconstructive Surgery, Gülhane Military Medical Academy, 06010 Etlik, Ankara, Turkey
    • ,
  • Serdar Öztürk

      Affiliations

    • Department of Plastic and Reconstructive Surgery, Gülhane Military Medical Academy, 06010 Etlik, Ankara, Turkey
    • ,
  • Deniz Erdoğan

      Affiliations

    • Department of Histology, Gazi University, Faculty of Medicine, 06300 Beşevler, Ankara, Turkey

References 

  1. Nalbandian RM, Henry RL, Balko KW, Adams V, Neuman NR. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J Biomed Mater Res. 1987;21:1135–1148
  2. Sheridan RL, Tompkins RG. Skin substitutes in burns. Burns. 1999;25:97–103
  3. Wysocki AB. Skin anatomy, physiology, and pathophysiology. Nurs Clin N Am. 1999;34:777–797
  4. O’Connor NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H. Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet. 1981;317:75–78
  5. Pearson AS, Wolford W. Management of skin trauma. Prim Care. 2000;27(2):475–492
  6. Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet. 1998;352:1661–1664
  7. Ueno H, Yamada H, Tanaka I, Kaba N, Matsuura M, Okumura M, et al. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials. 1999;20:1407–1414
  8. McCarthy DW, Downing MT, Brigstock DR, Luquette MH, Brown KD, Abad MS, et al. Production of heparin-binding epidermal growth factor-like growth-factor (Hb-EGF) at sites of thermal injury in pediatric patients. J Invest Dermatol. 1996;106(1):49–56
  9. Brown GL, Curtsinger LJ, White M, Mitchell RO, Pietsch J, Nordquist R, et al. Acceleration of tensile strength of incisions treated with EGF and TGF-β. Ann Surg. 1988;208(6):788–794
  10. Gönül B, Erdoğan D, Özoğul C, Koz M, Çelebi N. Effect of EGF dosage forms on alkali burned corneal wound healing of mice. Burns. 1995;21(1):7–10
  11. Møller S, Jensen M, Svenson P, Skakkebæk NE. Insulin-like growth factor 1 (IGF-1) in burn patients. Burns. 1991;17(4):279–281
  12. Kiyohara Y, Nishiguchi K, Komada F, Iwakawa S, Hirai M, Okumura K. Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn site in rats. Biol Pharm Bull. 1993;16(11):1146–1149
  13. Fu X, Shen Z, Chen Y, Xie J, Guo Z, Zhang M, et al. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet. 1998;352:1661–1664
  14. Robson MC, Mustoe TA, Hunt TK. The future of recombinant growth factors in wound healing. Am J Surg. 1998;176:80S–82S
  15. Steed DL. Modifying the wound healing response with exogenous growth factors. Clin Plast Surg. 1998;25(3):397–405
  16. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15(9):1326–1331
  17. Ishihara M, Ono K, Sato M, Nakanishi K, Saito Y, Yura H, et al. Acceleration of wound contraction and healing with a photocrosslinkable chitosan hydrogel. Wound Repair Regen. 2001;9(6):513–521
  18. Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52:105–115
  19. Howling GI, Dettmar PW, Goddard PA, Hampson FC, Dornish M, Wood EJ. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials. 2001;22:2959–2966
  20. Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, et al. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials. 2002;23:833–840
  21. Çelebi N, Erden N, Gönül B, Koz M. Effects of epidermal growth factor dosage forms on dermal wound strength in mice. J Pharm Pharmacol. 1993;46:386–387
  22. Çelebi N, Türkyılmaz A, Gönül B, Özoğul C. Effects of epidermal growth factor microemulsion formulation on the healing of stress-induced gastric ulcers in rats. J Control Release. 2002;83:197–210
  23. Araki F, Nakamura H, Nojima N, Tsukumo K, Sakamoto S. Stability of recombinant human epidermal growth factor in various solutions. Chem Pharm Bull. 1989;37(2):404–406
  24. Carpenter G, Cohe S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216
  25. Wenczak BA, Lynch JB, Nanney LB. Epidermal growth factor receptor distribution in burn wounds. J Clin Invest. 1992;90:2392–2401
  26. Nassif PS, Simpson SQ, Izzo AA, Nicklaus PJ. Epidermal growth factor and transforming growth factor-α in middle ear effusion. Otolaryngol Head Neck Surg. 1998;119(6):564–568
  27. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, et al. Epithelial wound healing enhanced by transforming growth factor-α and vaccinia growth factor. Science. 1987;235:350–352
  28. Doğan AK. Master degree thesis. Hacettepe University, Science Institute; 2003.
  29. Uhl KV, Furnschlief E, Wagner A, Ferko B, Katinger H. Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. Eur J Pharm Sci. 2001;14:63–67
  30. Sugihara H, Hattori T, Fukuda M. Immunohistochemical detection of bromodeoxyuridine in formalin-fixed tissues. Histochemistry. 1986;85:193–195
  31. Gilpin DA, Barrow RE, Rutan RL, Broemelling L, Herndon DN. Recombinant human growth factor hormone accelerates wound healing in children with large cutaneous burns. Ann Surg. 1994;220:19–24
  32. Conti B, Giunchedi P, Genta I, Conte U. The preparation and in vivo evaluation of the wound-healing properties of chitosan microspheres. STP Pharm Sci. 2000;10:101–104
  33. Değim Z, Çelebi N, Sayan H, Babül A, Erdoğan D, Take G. An investigation on skin wound healing in mice with a taurine–chitosan gel formulation. Amino Acids. 2002;22:187–198
  34. Bartone FF, Adickes E. Chitosan: effects on wound healing in urogenital tissue: preliminary report. J Urol. 1988;140:1134–1137
  35. Montelione GT, Wuthrich K, Burgess AW, Nice EC, Wagner G, Gibson KD, et al. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. Biochemistry. 1992;31(1):236–249
  36. Kohda D, Go N, Hayashi K, Inagaki F. Tertiary structure of mouse epidermal growth factor determined by two-dimensional 1H NMR. J Biochem. 1988;103(5):741–743
  37. The Merck Index. 12th ed. Whitehouse Station, NJ, USA: Merck & Co., Inc.; 1996. p. 595–6.
  38. Medved LV, Orthner CL, Lubon H, Lee TK, Drohan WN, Ingham KC. Thermal stability and domain–domain interactions in natural and recombinant protein C. Am Soc Biochem Mol Biol. 1995;270(23):13652–13659
  39. Maeda K, Kato Y, Sugiyama Y. pH-dependent receptor/ligand dissociation as a determining factor for intracellular sorting of ligands for epidermal growth factor receptors in rat hepatocytes. J Control Release. 2002;82(1):71–82
  40. Degreef H, Michiels JL. 1% silver sulfadiazine cream as a treatment for infected leg ulcers. Curr Ther Res. 1984;36:1190–1194

PII: S0305-4179(05)00296-2

doi: 10.1016/j.burns.2005.10.015

Burns
Volume 32, Issue 3 , Pages 319-327 , May 2006

Article Tools

* Image Usage & Resolution